Sign inJoin waitlistJoin the waitlist

ML

Michael Livingston

Physician · ABILITY NETWORK

Credentials: · · ·

History

CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY · LEVINE CANCER INSTITUTE · ABILITY NETWORK
Present

Hematology and Medical Oncology
1987–1990
Internal Medicine
1984–1987
Med Univ of South Carolina Coll of Med
1980–1984

Research

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
The Lancet · 2016 · 464 citations
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
Journal of Clinical Oncology · 2009 · 450 citations
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Journal of Clinical Oncology · 2019 · 215 citations

RM
Robert Maki
7 papers
DR
Daniel Rushing
5 papers
Mark Agulnik
5 papers
Scott Okuno
5 papers
WA
William Ahrens
5 papers
CR
Christopher Ryan
4 papers
CA
Colin Anderson
4 papers
DR
Damon Reed
4 papers
Jeffrey Kneisl
4 papers
Joshua Patt
4 papers
Kristen Ganjoo
4 papers
Margaret von Mehren
4 papers